Age-Related Decrease of Growth Hormone and Prolactin Gene Expression in the Mouse Pituitary*

Endocrinology ◽  
1987 ◽  
Vol 121 (4) ◽  
pp. 1251-1255 ◽  
Author(s):  
MARK D. CREW ◽  
STEPHEN R. SPINDLER ◽  
ROY L. WALFORD ◽  
AKIO KOIZUMI
1990 ◽  
Vol 72 (6) ◽  
pp. 879-882 ◽  
Author(s):  
Takashi Nagaya ◽  
Hisao Seo ◽  
Akio Kuwayama ◽  
Tsuyoshi Sakurai ◽  
Nobuhiro Tsukamoto ◽  
...  

✓ To elucidate the mechanism of hyperprolactinemia often observed in patients with growth hormone (GH)-secreting pituitary adenomas, the presence of immunoreactive prolactin (ir-PRL) and prolactin (PRL) messenger ribonucleic acid (mRNA) in the tumor tissue was examined by immunohistochemistry and cytoplasmic dot hybridization. Hyperprolactinemia was observed in three of 18 patients with GH-secreting adenoma. The tumor tissue was demonstrated to contain ir-PRL in nine patients and PRL mRNA in 13. The presence of ir-PRL in the tumor tissue was always associated with positive PRL mRNA, indicating production of PRL in GH-secreting tumors. Among the three patients with hyperprolactinemia, both ir-PRL and PRL mRNA was revealed in the tumor tissue of one, PRL mRNA but not ir-PRL was detected in the adenoma tissue of another, and neither PRL mRNA nor ir-PRL was found in the tumor tissue of the third. The association of hyperprolactinemia with the presence of both ir-PRL and PRL mRNA or PRL mRNA alone is indicative of PRL production and secretion. However, the absence of ir-PRL and PRL mRNA in the tumor tissue may indicate that hyperprolactinemia is caused by the suppression of PRL inhibitory factor due to hypothalamic dysfunction by the tumor mass. Thus, the study of PRL gene expression and immunohistochemistry in GH-secreting adenomas is valuable to understanding the pathophysiology of pituitary tumors.


Endocrinology ◽  
2007 ◽  
Vol 148 (12) ◽  
pp. 6107-6114 ◽  
Author(s):  
Anna Gruszka ◽  
Song-Guang Ren ◽  
Jesse Dong ◽  
Michael D. Culler ◽  
Shlomo Melmed

Endocrinology ◽  
2020 ◽  
Vol 162 (2) ◽  
Author(s):  
Mary P LaPierre ◽  
Svenja Godbersen ◽  
Mònica Torres Esteban ◽  
Anaïs Nura Schad ◽  
Mathias Treier ◽  
...  

Abstract Prolactin production is controlled by a complex and temporally dynamic network of factors. Despite this tightly coordinated system, pathological hyperprolactinemia is a common endocrine disorder that is often not understood, thereby highlighting the need to expand our molecular understanding of lactotroph cell regulation. MicroRNA-7 (miR-7) is the most highly expressed miRNA family in the pituitary gland and the loss of the miR-7 family member, miR-7a2, is sufficient to reduce prolactin gene expression in mice. Here, we used conditional loss-of-function and gain-of-function mouse models to characterize the function of miR-7a2 in lactotroph cells. We found that pituitary miR-7a2 expression undergoes developmental and sex hormone–dependent regulation. Unexpectedly, the loss of mir-7a2 induces a premature increase in prolactin expression and lactotroph abundance during embryonic development, followed by a gradual loss of prolactin into adulthood. On the other hand, lactotroph development is delayed in mice overexpressing miR-7a2. This regulation of lactotroph function by miR-7a2 involves complementary mechanisms in multiple cell populations. In mouse pituitary and rat prolactinoma cells, miR-7a2 represses its target Raf1, which promotes prolactin gene expression. These findings shed light on the complex regulation of prolactin production and may have implications for the physiological and pathological mechanisms underlying hyperprolactinemia.


Author(s):  
Carter Bancroft ◽  
Gregory G. Gick ◽  
Marcia E. Johnson ◽  
Bruce A. White

Endocrinology ◽  
1992 ◽  
Vol 131 (5) ◽  
pp. 2077-2082 ◽  
Author(s):  
M A Emanuele ◽  
J J Tentler ◽  
L Kirsteins ◽  
N V Emanuele ◽  
A Lawrence ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document